Crispr Stem & Therapeutics (CST)
Gene and Cell Therapy for Acute Myocardial Ischemia
Active
Pre-Funding
Startup
Petah Tikva
Founded 2018-05
Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. The company's technology will use CRISPR to genetically modify the patient's own stem cells, which are then treated by Crispr Stem & Therapeutics protocol and…
SectorHealth Tech & Life Sciences
StagePre-Funding
Total raised$100K
Employees1
Founded2018-05
HQPetah Tikva
Patents1
Confidence87
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCellsGenes
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology